Trinity Industries is a leading technology company focused on innovation and creating and monetizing its…
Goldman Sachs Patent Portfolio – Exemplary Landscape Overview
Goldman Sachs is a leading technology company focused on innovation and creating and monetizing its Intellectual Property across jurisdictions. This exemplary study/report presents a high-level brief analysis of the Patent Portfolio of the Corporate, and various attributes/parameters on which the said entities Patent Portfolio is being represented.
Goldman Sachs along with its key subsidiaries has a total of around 1687 patents/applications globally as of the date of the instant publication, out of which 447 patents have been issued. Of these 1687 patents/applications, more than 35.15% patents/applications are active. United States is where Goldman Sachs has filed the maximum number of patents, followed by World Intellectual Property Organization.
Most of the patents of the Goldman Sachs are in the classification of G06Q and G06F, which indicates the core areas of technology focus of the company.


The below graphical representation indicates yearly filing trends of the Goldman Sachs, which shows that the number of applications peaked in 2002 with 2023-2024 filings potentially still being recorded, indicating that the trend could rise further.
How many Goldman Sachs Portfolio patents are Alive/Dead?
Countries in which Goldman Sachs Filed Patents
10 Best Goldman Sachs Portfolio Patents
The patent US7287280 is the most cited in the portfolio, with 471 citations to date.
Goldman Sachs Portfolio Top 10 Inventors
Us is the top inventor with 1124 filings.
Patent Family with Most Filings

Disclaimer: This article is only being drafted/published for exemplary representation purposes based on public information and patent databases. The article does not, in any manner, intend to render any legal opinion, and also does not intend to warranty accuracy of the captured data being processed/represented. The analysis is only exemplary in nature, and therefore neither IIPRD nor any of its Partners, Employees, Associates, and/or Affiliates assume or admit any liability arising out of the same article and/or information provided therein.






